nodes	percent_of_prediction	percent_of_DWPC	metapath
Bosentan—CYP2C9—Formoterol—chronic obstructive pulmonary disease	0.098	0.182	CbGbCtD
Bosentan—CYP2C9—Arformoterol—chronic obstructive pulmonary disease	0.098	0.182	CbGbCtD
Bosentan—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0752	0.14	CbGbCtD
Bosentan—CYP2C9—Montelukast—chronic obstructive pulmonary disease	0.0743	0.138	CbGbCtD
Bosentan—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0508	0.0945	CbGbCtD
Bosentan—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0485	0.0902	CbGbCtD
Bosentan—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0432	0.0804	CbGbCtD
Bosentan—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.0253	0.0472	CbGbCtD
Bosentan—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.0239	0.0445	CbGbCtD
Bosentan—EDNRA—Prostaglandin Synthesis and Regulation—SCGB1A1—chronic obstructive pulmonary disease	0.00876	0.07	CbGpPWpGaD
Bosentan—EDNRA—EGFR-dependent Endothelin signaling events—EDN1—chronic obstructive pulmonary disease	0.0056	0.0448	CbGpPWpGaD
Bosentan—CYP3A4—Lidocaine metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00341	0.0273	CbGpPWpGaD
Bosentan—CYP3A4—Aflatoxin B1 metabolism—EPHX1—chronic obstructive pulmonary disease	0.00302	0.0241	CbGpPWpGaD
Bosentan—EDNRB—Prostaglandin Synthesis and Regulation—EDN1—chronic obstructive pulmonary disease	0.00299	0.0239	CbGpPWpGaD
Bosentan—EDNRB—Endothelin Pathways—EDN1—chronic obstructive pulmonary disease	0.00277	0.0221	CbGpPWpGaD
Bosentan—EDNRB—Peptide GPCRs—CXCR2—chronic obstructive pulmonary disease	0.00259	0.0207	CbGpPWpGaD
Bosentan—CYP3A4—Benzo(a)pyrene metabolism—EPHX1—chronic obstructive pulmonary disease	0.00247	0.0197	CbGpPWpGaD
Bosentan—EDNRA—EGFR-dependent Endothelin signaling events—EGFR—chronic obstructive pulmonary disease	0.00221	0.0177	CbGpPWpGaD
Bosentan—EDNRA—Prostaglandin Synthesis and Regulation—EDN1—chronic obstructive pulmonary disease	0.00214	0.0171	CbGpPWpGaD
Bosentan—EDNRA—Endothelin Pathways—EDN1—chronic obstructive pulmonary disease	0.00198	0.0158	CbGpPWpGaD
Bosentan—EDNRA—Peptide GPCRs—CXCR2—chronic obstructive pulmonary disease	0.00185	0.0148	CbGpPWpGaD
Bosentan—CYP2C9—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A2—chronic obstructive pulmonary disease	0.00171	0.0137	CbGpPWpGaD
Bosentan—EDNRB—Endothelin Pathways—NOS3—chronic obstructive pulmonary disease	0.00169	0.0135	CbGpPWpGaD
Bosentan—EDNRB—Endothelins—EDN1—chronic obstructive pulmonary disease	0.00165	0.0132	CbGpPWpGaD
Bosentan—ABCB11—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.00161	0.0129	CbGpPWpGaD
Bosentan—CYP2C9—Arachidonate Epoxygenase / Epoxide Hydrolase—GSTP1—chronic obstructive pulmonary disease	0.00158	0.0127	CbGpPWpGaD
Bosentan—EDNRA—GPCRs, Other—CXCR2—chronic obstructive pulmonary disease	0.00157	0.0125	CbGpPWpGaD
Bosentan—CYP2C9—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A2—chronic obstructive pulmonary disease	0.00155	0.0124	CbGpPWpGaD
Bosentan—ABCB11—Recycling of bile acids and salts—ALB—chronic obstructive pulmonary disease	0.00145	0.0116	CbGpPWpGaD
Bosentan—EDNRB—Endothelins—MMP1—chronic obstructive pulmonary disease	0.00139	0.0111	CbGpPWpGaD
Bosentan—CYP3A4—Aflatoxin B1 metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00125	0.01	CbGpPWpGaD
Bosentan—CYP2C9—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A1—chronic obstructive pulmonary disease	0.00124	0.00992	CbGpPWpGaD
Bosentan—EDNRB—Peptide ligand-binding receptors—CXCR2—chronic obstructive pulmonary disease	0.00122	0.00973	CbGpPWpGaD
Bosentan—EDNRA—Endothelin Pathways—NOS3—chronic obstructive pulmonary disease	0.00121	0.00965	CbGpPWpGaD
Bosentan—EDNRA—Endothelins—EDN1—chronic obstructive pulmonary disease	0.00118	0.00944	CbGpPWpGaD
Bosentan—CYP2C9—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—chronic obstructive pulmonary disease	0.00113	0.00903	CbGpPWpGaD
Bosentan—EDNRA—Endothelins—MMP1—chronic obstructive pulmonary disease	0.000992	0.00793	CbGpPWpGaD
Bosentan—EDNRA—GPCRs, Other—ADRB2—chronic obstructive pulmonary disease	0.000984	0.00787	CbGpPWpGaD
Bosentan—CYP3A4—Aflatoxin B1 metabolism—GSTM1—chronic obstructive pulmonary disease	0.00096	0.00768	CbGpPWpGaD
Bosentan—EDNRB—GPCRs, Class A Rhodopsin-like—CXCR2—chronic obstructive pulmonary disease	0.000952	0.00762	CbGpPWpGaD
Bosentan—EDNRA—Peptide ligand-binding receptors—CXCR2—chronic obstructive pulmonary disease	0.000871	0.00696	CbGpPWpGaD
Bosentan—CYP2C9—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.00082	0.00656	CbGpPWpGaD
Bosentan—EDNRB—Class A/1 (Rhodopsin-like receptors)—CXCR2—chronic obstructive pulmonary disease	0.000816	0.00653	CbGpPWpGaD
Bosentan—CYP2C9—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000789	0.00631	CbGpPWpGaD
Bosentan—EDNRA—GPCRs, Other—HTR2A—chronic obstructive pulmonary disease	0.000769	0.00615	CbGpPWpGaD
Bosentan—ABCB11—Bile acid and bile salt metabolism—ALB—chronic obstructive pulmonary disease	0.000758	0.00606	CbGpPWpGaD
Bosentan—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000744	0.00595	CbGpPWpGaD
Bosentan—EDNRB—G alpha (q) signalling events—EDN1—chronic obstructive pulmonary disease	0.000691	0.00552	CbGpPWpGaD
Bosentan—EDNRB—Peptide ligand-binding receptors—EDN1—chronic obstructive pulmonary disease	0.000682	0.00545	CbGpPWpGaD
Bosentan—EDNRA—GPCRs, Class A Rhodopsin-like—CXCR2—chronic obstructive pulmonary disease	0.000682	0.00545	CbGpPWpGaD
Bosentan—CYP3A4—Fatty Acid Omega Oxidation—CYP1A2—chronic obstructive pulmonary disease	0.000647	0.00517	CbGpPWpGaD
Bosentan—EDNRB—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	0.000621	0.00497	CbGpPWpGaD
Bosentan—EDNRB—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—chronic obstructive pulmonary disease	0.000618	0.00494	CbGpPWpGaD
Bosentan—EDNRB—G alpha (q) signalling events—HTR2A—chronic obstructive pulmonary disease	0.000604	0.00483	CbGpPWpGaD
Bosentan—EDNRB—GPCRs, Class A Rhodopsin-like—ADRB2—chronic obstructive pulmonary disease	0.000597	0.00478	CbGpPWpGaD
Bosentan—CYP2C9—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000596	0.00477	CbGpPWpGaD
Bosentan—CYP3A4—Estrogen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000588	0.00471	CbGpPWpGaD
Bosentan—EDNRA—Class A/1 (Rhodopsin-like receptors)—CXCR2—chronic obstructive pulmonary disease	0.000584	0.00467	CbGpPWpGaD
Bosentan—CYP2C9—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000573	0.00458	CbGpPWpGaD
Bosentan—CYP3A4—Aflatoxin activation and detoxification—CYP1A2—chronic obstructive pulmonary disease	0.000563	0.00451	CbGpPWpGaD
Bosentan—CYP3A4—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000541	0.00433	CbGpPWpGaD
Bosentan—EDNRB—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—chronic obstructive pulmonary disease	0.00054	0.00432	CbGpPWpGaD
Bosentan—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000536	0.00429	CbGpPWpGaD
Bosentan—CYP3A4—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00052	0.00416	CbGpPWpGaD
Bosentan—EDNRB—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	0.000512	0.00409	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	0.000509	0.00407	CbGpPWpGaD
Bosentan—EDNRA—G alpha (q) signalling events—EDN1—chronic obstructive pulmonary disease	0.000494	0.00395	CbGpPWpGaD
Bosentan—EDNRA—Peptide ligand-binding receptors—EDN1—chronic obstructive pulmonary disease	0.000488	0.0039	CbGpPWpGaD
Bosentan—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.00047	0.00376	CbGpPWpGaD
Bosentan—EDNRB—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	0.000467	0.00374	CbGpPWpGaD
Bosentan—EDNRB—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	0.000457	0.00366	CbGpPWpGaD
Bosentan—CYP3A4—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	0.000451	0.00361	CbGpPWpGaD
Bosentan—EDNRA—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	0.000445	0.00356	CbGpPWpGaD
Bosentan—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—chronic obstructive pulmonary disease	0.000442	0.00354	CbGpPWpGaD
Bosentan—EDNRB—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	0.000436	0.00348	CbGpPWpGaD
Bosentan—EDNRA—G alpha (q) signalling events—HTR2A—chronic obstructive pulmonary disease	0.000432	0.00346	CbGpPWpGaD
Bosentan—EDNRA—GPCRs, Class A Rhodopsin-like—ADRB2—chronic obstructive pulmonary disease	0.000428	0.00342	CbGpPWpGaD
Bosentan—CYP3A4—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000428	0.00342	CbGpPWpGaD
Bosentan—EDNRB—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	0.0004	0.0032	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	0.000396	0.00316	CbGpPWpGaD
Bosentan—CYP2C9—Arachidonic acid metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000394	0.00315	CbGpPWpGaD
Bosentan—CYP3A4—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000393	0.00314	CbGpPWpGaD
Bosentan—EDNRB—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	0.00039	0.00312	CbGpPWpGaD
Bosentan—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—chronic obstructive pulmonary disease	0.000387	0.00309	CbGpPWpGaD
Bosentan—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.000381	0.00113	CcSEcCtD
Bosentan—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.00038	0.00113	CcSEcCtD
Bosentan—Dry skin—Prednisolone—chronic obstructive pulmonary disease	0.000379	0.00112	CcSEcCtD
Bosentan—Cough—Salbutamol—chronic obstructive pulmonary disease	0.000379	0.00112	CcSEcCtD
Bosentan—CYP3A4—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000378	0.00302	CbGpPWpGaD
Bosentan—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.000375	0.00111	CcSEcCtD
Bosentan—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.000375	0.00111	CcSEcCtD
Bosentan—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.000375	0.00111	CcSEcCtD
Bosentan—Oedema—Formoterol—chronic obstructive pulmonary disease	0.000375	0.00111	CcSEcCtD
Bosentan—Ecchymosis—Prednisone—chronic obstructive pulmonary disease	0.000374	0.00111	CcSEcCtD
Bosentan—Infection—Arformoterol—chronic obstructive pulmonary disease	0.000373	0.0011	CcSEcCtD
Bosentan—Infection—Formoterol—chronic obstructive pulmonary disease	0.000373	0.0011	CcSEcCtD
Bosentan—ABCB11—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.000371	0.00297	CbGpPWpGaD
Bosentan—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.00037	0.00109	CcSEcCtD
Bosentan—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.00037	0.00109	CcSEcCtD
Bosentan—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000369	0.00109	CcSEcCtD
Bosentan—EDNRB—Peptide ligand-binding receptors—CXCL8—chronic obstructive pulmonary disease	0.000369	0.00295	CbGpPWpGaD
Bosentan—Pulmonary oedema—Prednisone—chronic obstructive pulmonary disease	0.000368	0.00109	CcSEcCtD
Bosentan—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.000368	0.00109	CcSEcCtD
Bosentan—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000368	0.00109	CcSEcCtD
Bosentan—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.000368	0.00109	CcSEcCtD
Bosentan—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000368	0.00109	CcSEcCtD
Bosentan—Oedema—Montelukast—chronic obstructive pulmonary disease	0.000368	0.00109	CcSEcCtD
Bosentan—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.000368	0.00109	CcSEcCtD
Bosentan—EDNRA—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	0.000366	0.00293	CbGpPWpGaD
Bosentan—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.000366	0.00108	CcSEcCtD
Bosentan—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.000366	0.00108	CcSEcCtD
Bosentan—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000365	0.00108	CcSEcCtD
Bosentan—Infection—Montelukast—chronic obstructive pulmonary disease	0.000365	0.00108	CcSEcCtD
Bosentan—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.000365	0.00108	CcSEcCtD
Bosentan—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000365	0.00108	CcSEcCtD
Bosentan—EDNRA—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	0.000364	0.00291	CbGpPWpGaD
Bosentan—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000363	0.00108	CcSEcCtD
Bosentan—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000362	0.00107	CcSEcCtD
Bosentan—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.00036	0.00107	CcSEcCtD
Bosentan—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.00036	0.00107	CcSEcCtD
Bosentan—Abdominal distension—Prednisolone—chronic obstructive pulmonary disease	0.00036	0.00107	CcSEcCtD
Bosentan—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000357	0.00106	CcSEcCtD
Bosentan—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.000354	0.00105	CcSEcCtD
Bosentan—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000354	0.00105	CcSEcCtD
Bosentan—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000354	0.00283	CbGpPWpGaD
Bosentan—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000352	0.00104	CcSEcCtD
Bosentan—EDNRB—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	0.000351	0.00281	CbGpPWpGaD
Bosentan—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000351	0.00104	CcSEcCtD
Bosentan—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000351	0.00104	CcSEcCtD
Bosentan—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000349	0.00103	CcSEcCtD
Bosentan—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000349	0.00103	CcSEcCtD
Bosentan—EDNRB—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	0.000348	0.00279	CbGpPWpGaD
Bosentan—CYP2C9—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000348	0.00279	CbGpPWpGaD
Bosentan—Sweating increased—Prednisolone—chronic obstructive pulmonary disease	0.000348	0.00103	CcSEcCtD
Bosentan—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000347	0.00103	CcSEcCtD
Bosentan—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000346	0.00102	CcSEcCtD
Bosentan—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000344	0.00102	CcSEcCtD
Bosentan—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000343	0.00101	CcSEcCtD
Bosentan—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000343	0.00101	CcSEcCtD
Bosentan—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000342	0.00101	CcSEcCtD
Bosentan—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000342	0.00101	CcSEcCtD
Bosentan—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000341	0.00272	CbGpPWpGaD
Bosentan—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000339	0.001	CcSEcCtD
Bosentan—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000339	0.001	CcSEcCtD
Bosentan—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000338	0.001	CcSEcCtD
Bosentan—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000337	0.000999	CcSEcCtD
Bosentan—CYP2C9—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000336	0.00269	CbGpPWpGaD
Bosentan—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000335	0.000992	CcSEcCtD
Bosentan—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000335	0.000991	CcSEcCtD
Bosentan—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000335	0.000991	CcSEcCtD
Bosentan—EDNRA—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	0.000334	0.00267	CbGpPWpGaD
Bosentan—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000334	0.000988	CcSEcCtD
Bosentan—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000334	0.000988	CcSEcCtD
Bosentan—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000332	0.000984	CcSEcCtD
Bosentan—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000331	0.00098	CcSEcCtD
Bosentan—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.00033	0.000978	CcSEcCtD
Bosentan—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.00033	0.000978	CcSEcCtD
Bosentan—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.00033	0.000977	CcSEcCtD
Bosentan—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000329	0.000974	CcSEcCtD
Bosentan—EDNRA—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	0.000327	0.00262	CbGpPWpGaD
Bosentan—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000327	0.000968	CcSEcCtD
Bosentan—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000326	0.000965	CcSEcCtD
Bosentan—Weight increased—Prednisolone—chronic obstructive pulmonary disease	0.000325	0.000963	CcSEcCtD
Bosentan—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000324	0.000959	CcSEcCtD
Bosentan—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000324	0.000959	CcSEcCtD
Bosentan—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000324	0.000958	CcSEcCtD
Bosentan—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000324	0.000958	CcSEcCtD
Bosentan—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000324	0.000958	CcSEcCtD
Bosentan—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000323	0.000956	CcSEcCtD
Bosentan—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000321	0.00095	CcSEcCtD
Bosentan—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000321	0.00095	CcSEcCtD
Bosentan—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000321	0.00095	CcSEcCtD
Bosentan—Pain—Formoterol—chronic obstructive pulmonary disease	0.000321	0.00095	CcSEcCtD
Bosentan—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.00032	0.000949	CcSEcCtD
Bosentan—EDNRB—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	0.000319	0.00255	CbGpPWpGaD
Bosentan—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000318	0.000942	CcSEcCtD
Bosentan—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000317	0.00094	CcSEcCtD
Bosentan—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000317	0.000938	CcSEcCtD
Bosentan—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000316	0.000935	CcSEcCtD
Bosentan—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000315	0.000933	CcSEcCtD
Bosentan—Pain—Montelukast—chronic obstructive pulmonary disease	0.000314	0.000931	CcSEcCtD
Bosentan—Acute coronary syndrome—Prednisolone—chronic obstructive pulmonary disease	0.000314	0.00093	CcSEcCtD
Bosentan—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000314	0.000928	CcSEcCtD
Bosentan—Myocardial infarction—Prednisolone—chronic obstructive pulmonary disease	0.000312	0.000925	CcSEcCtD
Bosentan—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000312	0.000924	CcSEcCtD
Bosentan—EDNRA—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	0.000312	0.00249	CbGpPWpGaD
Bosentan—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000311	0.000921	CcSEcCtD
Bosentan—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000311	0.00092	CcSEcCtD
Bosentan—Conjunctivitis—Prednisolone—chronic obstructive pulmonary disease	0.00031	0.000917	CcSEcCtD
Bosentan—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000309	0.000915	CcSEcCtD
Bosentan—EDNRB—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	0.000308	0.00247	CbGpPWpGaD
Bosentan—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000308	0.000912	CcSEcCtD
Bosentan—Cardiac failure—Prednisone—chronic obstructive pulmonary disease	0.000308	0.000912	CcSEcCtD
Bosentan—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000307	0.00091	CcSEcCtD
Bosentan—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000307	0.000909	CcSEcCtD
Bosentan—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000307	0.000909	CcSEcCtD
Bosentan—Lethargy—Prednisone—chronic obstructive pulmonary disease	0.000307	0.000908	CcSEcCtD
Bosentan—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000306	0.000906	CcSEcCtD
Bosentan—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000305	0.000905	CcSEcCtD
Bosentan—EDNRB—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	0.000305	0.00244	CbGpPWpGaD
Bosentan—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000303	0.000897	CcSEcCtD
Bosentan—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000303	0.000897	CcSEcCtD
Bosentan—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000301	0.00089	CcSEcCtD
Bosentan—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000298	0.000883	CcSEcCtD
Bosentan—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000298	0.000883	CcSEcCtD
Bosentan—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000297	0.000878	CcSEcCtD
Bosentan—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000297	0.000878	CcSEcCtD
Bosentan—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000297	0.000878	CcSEcCtD
Bosentan—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000297	0.000878	CcSEcCtD
Bosentan—Affect lability—Prednisone—chronic obstructive pulmonary disease	0.000296	0.000876	CcSEcCtD
Bosentan—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000296	0.000875	CcSEcCtD
Bosentan—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000293	0.000868	CcSEcCtD
Bosentan—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000293	0.000867	CcSEcCtD
Bosentan—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000293	0.000867	CcSEcCtD
Bosentan—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000292	0.000865	CcSEcCtD
Bosentan—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000291	0.000863	CcSEcCtD
Bosentan—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	0.000291	0.000862	CcSEcCtD
Bosentan—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000291	0.00086	CcSEcCtD
Bosentan—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000291	0.00086	CcSEcCtD
Bosentan—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.00029	0.000858	CcSEcCtD
Bosentan—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	0.000288	0.000851	CcSEcCtD
Bosentan—Irritability—Prednisone—chronic obstructive pulmonary disease	0.000287	0.000849	CcSEcCtD
Bosentan—EDNRA—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	0.000286	0.00229	CbGpPWpGaD
Bosentan—CYP2C9—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000286	0.00229	CbGpPWpGaD
Bosentan—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	0.000286	0.000847	CcSEcCtD
Bosentan—Cardiac arrest—Prednisone—chronic obstructive pulmonary disease	0.000286	0.000846	CcSEcCtD
Bosentan—Mood swings—Prednisone—chronic obstructive pulmonary disease	0.000285	0.000843	CcSEcCtD
Bosentan—EDNRA—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	0.000283	0.00226	CbGpPWpGaD
Bosentan—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000281	0.000833	CcSEcCtD
Bosentan—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.00028	0.000829	CcSEcCtD
Bosentan—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.00028	0.000829	CcSEcCtD
Bosentan—EDNRA—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	0.000279	0.00223	CbGpPWpGaD
Bosentan—CYP3A4—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000278	0.00222	CbGpPWpGaD
Bosentan—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000276	0.000819	CcSEcCtD
Bosentan—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000276	0.000819	CcSEcCtD
Bosentan—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000276	0.000818	CcSEcCtD
Bosentan—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000276	0.00221	CbGpPWpGaD
Bosentan—Dry skin—Prednisone—chronic obstructive pulmonary disease	0.000275	0.000816	CcSEcCtD
Bosentan—Hypokalaemia—Prednisone—chronic obstructive pulmonary disease	0.000273	0.00081	CcSEcCtD
Bosentan—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000271	0.000802	CcSEcCtD
Bosentan—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000269	0.000797	CcSEcCtD
Bosentan—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000269	0.000797	CcSEcCtD
Bosentan—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000266	0.000786	CcSEcCtD
Bosentan—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000266	0.000786	CcSEcCtD
Bosentan—EDNRA—Peptide ligand-binding receptors—CXCL8—chronic obstructive pulmonary disease	0.000264	0.00211	CbGpPWpGaD
Bosentan—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000264	0.000781	CcSEcCtD
Bosentan—Abdominal distension—Prednisone—chronic obstructive pulmonary disease	0.000261	0.000774	CcSEcCtD
Bosentan—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000261	0.000773	CcSEcCtD
Bosentan—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.00026	0.00077	CcSEcCtD
Bosentan—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000257	0.00076	CcSEcCtD
Bosentan—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000257	0.00076	CcSEcCtD
Bosentan—ABCB11—Metabolism—APIP—chronic obstructive pulmonary disease	0.000257	0.00205	CbGpPWpGaD
Bosentan—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000254	0.000753	CcSEcCtD
Bosentan—Sweating increased—Prednisone—chronic obstructive pulmonary disease	0.000253	0.000749	CcSEcCtD
Bosentan—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000251	0.000745	CcSEcCtD
Bosentan—EDNRA—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	0.000251	0.00201	CbGpPWpGaD
Bosentan—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000251	0.000742	CcSEcCtD
Bosentan—EDNRA—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	0.000249	0.00199	CbGpPWpGaD
Bosentan—Erythema—Prednisolone—chronic obstructive pulmonary disease	0.000249	0.000737	CcSEcCtD
Bosentan—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000248	0.000735	CcSEcCtD
Bosentan—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000248	0.000735	CcSEcCtD
Bosentan—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000247	0.00198	CbGpPWpGaD
Bosentan—EDNRB—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	0.000247	0.00198	CbGpPWpGaD
Bosentan—CYP2C9—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000244	0.00195	CbGpPWpGaD
Bosentan—EDNRB—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—chronic obstructive pulmonary disease	0.000244	0.00195	CbGpPWpGaD
Bosentan—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000243	0.00072	CcSEcCtD
Bosentan—Neutropenia—Prednisone—chronic obstructive pulmonary disease	0.000243	0.000719	CcSEcCtD
Bosentan—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000242	0.000718	CcSEcCtD
Bosentan—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000239	0.000706	CcSEcCtD
Bosentan—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000239	0.000706	CcSEcCtD
Bosentan—Rash—Formoterol—chronic obstructive pulmonary disease	0.000237	0.000701	CcSEcCtD
Bosentan—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000237	0.000701	CcSEcCtD
Bosentan—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000236	0.0007	CcSEcCtD
Bosentan—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000236	0.0007	CcSEcCtD
Bosentan—Weight increased—Prednisone—chronic obstructive pulmonary disease	0.000236	0.0007	CcSEcCtD
Bosentan—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000235	0.000696	CcSEcCtD
Bosentan—Headache—Formoterol—chronic obstructive pulmonary disease	0.000235	0.000696	CcSEcCtD
Bosentan—Weight decreased—Prednisone—chronic obstructive pulmonary disease	0.000235	0.000696	CcSEcCtD
Bosentan—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.000235	0.000695	CcSEcCtD
Bosentan—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000234	0.000694	CcSEcCtD
Bosentan—Hyperglycaemia—Prednisone—chronic obstructive pulmonary disease	0.000234	0.000694	CcSEcCtD
Bosentan—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000234	0.000692	CcSEcCtD
Bosentan—EDNRB—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	0.000234	0.00187	CbGpPWpGaD
Bosentan—Rash—Montelukast—chronic obstructive pulmonary disease	0.000232	0.000686	CcSEcCtD
Bosentan—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000232	0.000686	CcSEcCtD
Bosentan—Headache—Montelukast—chronic obstructive pulmonary disease	0.00023	0.000682	CcSEcCtD
Bosentan—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.00023	0.00184	CbGpPWpGaD
Bosentan—Acute coronary syndrome—Prednisone—chronic obstructive pulmonary disease	0.000228	0.000676	CcSEcCtD
Bosentan—EDNRA—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	0.000228	0.00183	CbGpPWpGaD
Bosentan—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.000228	0.000674	CcSEcCtD
Bosentan—Myocardial infarction—Prednisone—chronic obstructive pulmonary disease	0.000227	0.000672	CcSEcCtD
Bosentan—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000225	0.000667	CcSEcCtD
Bosentan—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000225	0.0018	CbGpPWpGaD
Bosentan—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.000224	0.000662	CcSEcCtD
Bosentan—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000223	0.000662	CcSEcCtD
Bosentan—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.000223	0.000661	CcSEcCtD
Bosentan—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000223	0.000661	CcSEcCtD
Bosentan—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000223	0.00066	CcSEcCtD
Bosentan—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000223	0.00066	CcSEcCtD
Bosentan—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000222	0.000657	CcSEcCtD
Bosentan—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000222	0.00177	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	0.000221	0.00177	CbGpPWpGaD
Bosentan—EDNRB—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	0.00022	0.00176	CbGpPWpGaD
Bosentan—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.000219	0.000648	CcSEcCtD
Bosentan—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000218	0.000646	CcSEcCtD
Bosentan—EDNRA—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	0.000218	0.00174	CbGpPWpGaD
Bosentan—Bradycardia—Prednisone—chronic obstructive pulmonary disease	0.000212	0.000627	CcSEcCtD
Bosentan—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.00021	0.000623	CcSEcCtD
Bosentan—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.000209	0.00062	CcSEcCtD
Bosentan—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	0.000209	0.000619	CcSEcCtD
Bosentan—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000208	0.000615	CcSEcCtD
Bosentan—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.000203	0.000602	CcSEcCtD
Bosentan—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.000203	0.000602	CcSEcCtD
Bosentan—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000202	0.00161	CbGpPWpGaD
Bosentan—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000201	0.0016	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	0.0002	0.0016	CbGpPWpGaD
Bosentan—Shock—Prednisolone—chronic obstructive pulmonary disease	0.0002	0.000592	CcSEcCtD
Bosentan—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.000198	0.000587	CcSEcCtD
Bosentan—EDNRB—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	0.000197	0.00157	CbGpPWpGaD
Bosentan—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.000196	0.000582	CcSEcCtD
Bosentan—Eye disorder—Prednisone—chronic obstructive pulmonary disease	0.000194	0.000575	CcSEcCtD
Bosentan—Flushing—Prednisone—chronic obstructive pulmonary disease	0.000193	0.000571	CcSEcCtD
Bosentan—Angiopathy—Prednisone—chronic obstructive pulmonary disease	0.000189	0.000558	CcSEcCtD
Bosentan—EDNRB—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	0.000188	0.00151	CbGpPWpGaD
Bosentan—EDNRB—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	0.000188	0.00151	CbGpPWpGaD
Bosentan—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	0.000188	0.000556	CcSEcCtD
Bosentan—EDNRB—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic obstructive pulmonary disease	0.000188	0.0015	CbGpPWpGaD
Bosentan—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000184	0.000544	CcSEcCtD
Bosentan—ABCB11—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	0.000183	0.00146	CbGpPWpGaD
Bosentan—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000182	0.00054	CcSEcCtD
Bosentan—Mental disorder—Prednisone—chronic obstructive pulmonary disease	0.000182	0.000539	CcSEcCtD
Bosentan—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000182	0.00146	CbGpPWpGaD
Bosentan—Malnutrition—Prednisone—chronic obstructive pulmonary disease	0.000181	0.000536	CcSEcCtD
Bosentan—Erythema—Prednisone—chronic obstructive pulmonary disease	0.000181	0.000536	CcSEcCtD
Bosentan—EDNRB—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	0.000179	0.00143	CbGpPWpGaD
Bosentan—EDNRA—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	0.000177	0.00142	CbGpPWpGaD
Bosentan—CYP2C9—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000176	0.00141	CbGpPWpGaD
Bosentan—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—chronic obstructive pulmonary disease	0.000175	0.0014	CbGpPWpGaD
Bosentan—CYP2C9—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000174	0.0014	CbGpPWpGaD
Bosentan—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000174	0.000515	CcSEcCtD
Bosentan—EDNRB—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	0.000172	0.00138	CbGpPWpGaD
Bosentan—Vision blurred—Prednisone—chronic obstructive pulmonary disease	0.000171	0.000505	CcSEcCtD
Bosentan—ABCB11—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.00017	0.00136	CbGpPWpGaD
Bosentan—ABCB11—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	0.000169	0.00135	CbGpPWpGaD
Bosentan—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.000167	0.000495	CcSEcCtD
Bosentan—EDNRA—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	0.000167	0.00134	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—GC—chronic obstructive pulmonary disease	0.000165	0.00132	CbGpPWpGaD
Bosentan—Angioedema—Prednisone—chronic obstructive pulmonary disease	0.000165	0.00049	CcSEcCtD
Bosentan—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000163	0.00131	CbGpPWpGaD
Bosentan—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.000163	0.000481	CcSEcCtD
Bosentan—Syncope—Prednisone—chronic obstructive pulmonary disease	0.000162	0.00048	CcSEcCtD
Bosentan—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000161	0.000478	CcSEcCtD
Bosentan—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000161	0.00129	CbGpPWpGaD
Bosentan—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	0.000159	0.000471	CcSEcCtD
Bosentan—EDNRA—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	0.000158	0.00126	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	0.000156	0.00125	CbGpPWpGaD
Bosentan—Arthralgia—Prednisone—chronic obstructive pulmonary disease	0.000154	0.000456	CcSEcCtD
Bosentan—ABCB11—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000154	0.00123	CbGpPWpGaD
Bosentan—Anxiety—Prednisone—chronic obstructive pulmonary disease	0.000154	0.000455	CcSEcCtD
Bosentan—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.000153	0.000453	CcSEcCtD
Bosentan—Discomfort—Prednisone—chronic obstructive pulmonary disease	0.000152	0.000451	CcSEcCtD
Bosentan—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.00015	0.000443	CcSEcCtD
Bosentan—Oedema—Prednisone—chronic obstructive pulmonary disease	0.000148	0.000437	CcSEcCtD
Bosentan—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	0.000148	0.000437	CcSEcCtD
Bosentan—Infection—Prednisone—chronic obstructive pulmonary disease	0.000147	0.000434	CcSEcCtD
Bosentan—CYP2C9—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000147	0.00117	CbGpPWpGaD
Bosentan—Shock—Prednisone—chronic obstructive pulmonary disease	0.000145	0.00043	CcSEcCtD
Bosentan—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.000145	0.000429	CcSEcCtD
Bosentan—CYP2C9—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000145	0.00116	CbGpPWpGaD
Bosentan—Tachycardia—Prednisone—chronic obstructive pulmonary disease	0.000144	0.000427	CcSEcCtD
Bosentan—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.000143	0.000425	CcSEcCtD
Bosentan—EDNRA—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	0.000143	0.00115	CbGpPWpGaD
Bosentan—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.000143	0.000423	CcSEcCtD
Bosentan—EDNRA—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	0.000141	0.00113	CbGpPWpGaD
Bosentan—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.000141	0.000417	CcSEcCtD
Bosentan—EDNRB—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	0.000138	0.0011	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	0.000135	0.00108	CbGpPWpGaD
Bosentan—EDNRA—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	0.000135	0.00108	CbGpPWpGaD
Bosentan—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.000135	0.000398	CcSEcCtD
Bosentan—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000134	0.000398	CcSEcCtD
Bosentan—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic obstructive pulmonary disease	0.000134	0.00107	CbGpPWpGaD
Bosentan—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.000134	0.000396	CcSEcCtD
Bosentan—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.000133	0.000393	CcSEcCtD
Bosentan—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000132	0.00106	CbGpPWpGaD
Bosentan—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.00013	0.000385	CcSEcCtD
Bosentan—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.000128	0.00038	CcSEcCtD
Bosentan—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000128	0.000379	CcSEcCtD
Bosentan—EDNRB—Signaling Pathways—KL—chronic obstructive pulmonary disease	0.000128	0.00102	CbGpPWpGaD
Bosentan—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000128	0.000379	CcSEcCtD
Bosentan—EDNRA—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	0.000128	0.00102	CbGpPWpGaD
Bosentan—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000127	0.000377	CcSEcCtD
Bosentan—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000127	0.000377	CcSEcCtD
Bosentan—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000126	0.000374	CcSEcCtD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.000124	0.000992	CbGpPWpGaD
Bosentan—EDNRA—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	0.000123	0.000986	CbGpPWpGaD
Bosentan—ABCB11—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	0.000123	0.00098	CbGpPWpGaD
Bosentan—CYP2C9—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000122	0.000978	CbGpPWpGaD
Bosentan—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000121	0.000358	CcSEcCtD
Bosentan—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000121	0.000357	CcSEcCtD
Bosentan—CYP2C9—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.000121	0.000965	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	0.000118	0.000945	CbGpPWpGaD
Bosentan—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.000117	0.000347	CcSEcCtD
Bosentan—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000117	0.000346	CcSEcCtD
Bosentan—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000117	0.000346	CcSEcCtD
Bosentan—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000116	0.000931	CbGpPWpGaD
Bosentan—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000115	0.00092	CbGpPWpGaD
Bosentan—CYP2C9—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000112	0.000899	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	0.000112	0.000895	CbGpPWpGaD
Bosentan—CYP2C9—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	0.000111	0.000887	CbGpPWpGaD
Bosentan—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000109	0.000322	CcSEcCtD
Bosentan—CYP2C9—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.000107	0.000852	CbGpPWpGaD
Bosentan—EDNRB—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	0.000106	0.000851	CbGpPWpGaD
Bosentan—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000106	0.000314	CcSEcCtD
Bosentan—EDNRB—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	0.000106	0.000845	CbGpPWpGaD
Bosentan—CYP2C9—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	0.000105	0.000841	CbGpPWpGaD
Bosentan—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000104	0.000309	CcSEcCtD
Bosentan—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000101	0.000299	CcSEcCtD
Bosentan—EDNRA—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	9.86e-05	0.000788	CbGpPWpGaD
Bosentan—Dizziness—Prednisone—chronic obstructive pulmonary disease	9.77e-05	0.000289	CcSEcCtD
Bosentan—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	9.67e-05	0.000774	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	9.66e-05	0.000773	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	9.6e-05	0.000768	CbGpPWpGaD
Bosentan—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	9.54e-05	0.000763	CbGpPWpGaD
Bosentan—Vomiting—Prednisone—chronic obstructive pulmonary disease	9.39e-05	0.000278	CcSEcCtD
Bosentan—Rash—Prednisone—chronic obstructive pulmonary disease	9.31e-05	0.000276	CcSEcCtD
Bosentan—Dermatitis—Prednisone—chronic obstructive pulmonary disease	9.3e-05	0.000275	CcSEcCtD
Bosentan—Headache—Prednisone—chronic obstructive pulmonary disease	9.25e-05	0.000274	CcSEcCtD
Bosentan—EDNRB—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	9.24e-05	0.000739	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—KL—chronic obstructive pulmonary disease	9.16e-05	0.000733	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—GSTT1—chronic obstructive pulmonary disease	9.04e-05	0.000723	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—GCLC—chronic obstructive pulmonary disease	8.93e-05	0.000715	CbGpPWpGaD
Bosentan—Nausea—Prednisone—chronic obstructive pulmonary disease	8.77e-05	0.00026	CcSEcCtD
Bosentan—EDNRB—Signaling Pathways—LEP—chronic obstructive pulmonary disease	8.59e-05	0.000687	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—APIP—chronic obstructive pulmonary disease	8.57e-05	0.000686	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	8.46e-05	0.000676	CbGpPWpGaD
Bosentan—ABCB11—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	8.33e-05	0.000666	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—CTGF—chronic obstructive pulmonary disease	8.15e-05	0.000652	CbGpPWpGaD
Bosentan—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	8.07e-05	0.000645	CbGpPWpGaD
Bosentan—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	7.96e-05	0.000636	CbGpPWpGaD
Bosentan—EDNRA—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	7.61e-05	0.000609	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	7.56e-05	0.000604	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—CYP1A2—chronic obstructive pulmonary disease	7.51e-05	0.000601	CbGpPWpGaD
Bosentan—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	7.41e-05	0.000593	CbGpPWpGaD
Bosentan—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	7.31e-05	0.000585	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	7.06e-05	0.000565	CbGpPWpGaD
Bosentan—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	7.03e-05	0.000562	CbGpPWpGaD
Bosentan—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	6.93e-05	0.000554	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	6.91e-05	0.000553	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	6.87e-05	0.000549	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	6.74e-05	0.000539	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	6.61e-05	0.000529	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	6.43e-05	0.000515	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.26e-05	0.000501	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.18e-05	0.000494	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—LEP—chronic obstructive pulmonary disease	6.15e-05	0.000492	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	6.11e-05	0.000489	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.76e-05	0.00046	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	5.71e-05	0.000456	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	5.68e-05	0.000454	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	5.65e-05	0.000452	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	5.63e-05	0.00045	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—GC—chronic obstructive pulmonary disease	5.52e-05	0.000442	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.46e-05	0.000437	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	5.43e-05	0.000434	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	5.16e-05	0.000413	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	5.14e-05	0.000411	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	5.05e-05	0.000404	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	4.82e-05	0.000386	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	4.64e-05	0.000371	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	4.6e-05	0.000368	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	4.25e-05	0.00034	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	4.17e-05	0.000334	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	4.09e-05	0.000327	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	4.08e-05	0.000327	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	3.88e-05	0.000311	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.74e-05	0.0003	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—ALB—chronic obstructive pulmonary disease	3.71e-05	0.000297	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	3.69e-05	0.000295	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	3.64e-05	0.000291	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—NOS3—chronic obstructive pulmonary disease	3.55e-05	0.000284	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.5e-05	0.00028	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.39e-05	0.000271	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.32e-05	0.000265	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.21e-05	0.000256	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.04e-05	0.000244	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.02e-05	0.000241	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.99e-05	0.000239	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—GCLC—chronic obstructive pulmonary disease	2.98e-05	0.000239	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	2.78e-05	0.000222	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—CTGF—chronic obstructive pulmonary disease	2.72e-05	0.000218	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.51e-05	0.000201	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.51e-05	0.0002	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.29e-05	0.000184	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.09e-05	0.000167	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.06e-05	0.000165	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.99e-05	0.000159	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	1.97e-05	0.000157	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.92e-05	0.000154	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.82e-05	0.000146	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	1.8e-05	0.000144	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.65e-05	0.000132	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.38e-05	0.00011	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.36e-05	0.000109	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.27e-05	0.000101	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—ALB—chronic obstructive pulmonary disease	1.24e-05	9.91e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.2e-05	9.61e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—NOS3—chronic obstructive pulmonary disease	1.18e-05	9.48e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	8.17e-06	6.53e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	7.81e-06	6.25e-05	CbGpPWpGaD
